Schematic and photograph of COVID-19 sensor strip and the printed circuit board fabricated to produce a digital sensor output.
CREDIT: Minghan Xian, Hao Luo, Xinyi Xia, Chaker Fares, Patrick H. Carey IV, Chan-Wen Chiu, Fan Ren, Siang-Sin Shan, Yu-Te Liao, Shu-Min Hsu, Josephine F. Esquivel-Upshaw, Chin-Wei Chang, Jenshan Lin, Steven C. Ghivizzani, and Stephen J. Pearton
The COVID-19 pandemic made it clear technological innovations were urgently needed to detect, treat, and prevent the SARS-CoV-2 virus. A year and a half into this epidemic, waves of successive outbreaks and the dire need for new medical solutions — especially testing — continue to exist.
In the Journal of Vacuum Science & Technology B, researchers from the University of Florida and Taiwan’s National Chiao Tung University report a rapid and sensitive testing method for COVID-19 biomarkers.
The researchers, who previously demonstrated detection of biomarkers relevant in epidemics and emergencies, such as the Zika virus, heart attacks, and cerebral spinal fluid leaks, leveraged their expertise to develop a sensor system that provides detection within one second, which is far faster than current COVID-19 detection methods.
“This could alleviate slow COVID-19 testing turnaround time issues,” said Minghan Xian, an author and a chemical engineering doctoral candidate at the University of Florida.
Detecting the presence of the virus requires amplifying the numbers of the biomarker, such as the copies of viral ribonucleic acid in the common polymerase chain reaction technique for COVID-19 detection, or amplifying the binding signal for a target biomarker. The group’s method amplifies the binding signal for a target biomarker.
“Our biosensor strip is similar to commercially available glucose test strips in shape, with a small microfluidic channel at the tip to introduce our test fluid,” said Xian. “Within the microfluidic channel, a few electrodes are exposed to fluid. One is coated with gold, and COVID-relevant antibodies are attached to the gold surface via a chemical method.”
During measurement, sensor strips are connected to a circuit board via a connector, and a short electrical test signal gets sent between the gold electrode bonded with COVID antibody and another auxiliary electrode. This signal is then returned to the circuit board for analysis.
“Our sensor system, a circuit board, uses a transistor to amplify the electrical signal, which then gets converted into a number on the screen,” said Xian. “The magnitude of this number depends on the concentration of antigen, the viral protein, present within our test solution.”
While the system’s sensor strips clearly must be discarded after use, the test circuit board is reusable. This means the cost of testing may be greatly reduced. The versatility of this technology goes far beyond detecting COIVD-19.
“By altering the type of antibodies attached to the gold surface, we can repurpose the system to detect other diseases,” said Xian. “The system can serve as a prototype for modularized, inexpensive protein biomarker sensors for expedient real-time feedback within clinical applications, operating rooms, or home use.”
Original Article: COVID-19 Testing Method Gives Results Within One Second
More from: University of Florida | National Chiao Tung University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 testing
- Chinese scientist who published COVID-19 virus sequence allowed back in his lab after sit-in protest
The first scientist to publish a sequence of the COVID-19 virus in China says he has been allowed back into his lab after days of protest ...
- COVID-19 outbreak at Blind River’s North Shore Health Network
COVID-19 has been confirmed on the acute care unit of the North Shore Health Network (NSHN), prompting Algoma Public Health to declare an outbreak at the Blind River site.
- ESCMID Presenters Make Case for Saliva Samples in Molecular Infectious Disease Testing
As demonstrated during the COVID-19 pandemic and in newer research, saliva holds promise as an alternative sample type for PCR-based infectious disease testing.
- J&J Beats Christian Worker’s Suit Over Covid Nasal Swab Testing
A Johnson & Johnson Services Inc. employee failed with claims that she was denied accommodation for and fired because of her Christian-based religious objection to nasal swab testing for Covid-19.
- New Brunswick mulls future of COVID-19 rapid tests, as virus kills 2, hospitalizes child under 4
New Brunswick is mulling the future of its COVID-19 rapid point of care testing program, as the virus claimed two more lives and hospitalized 17 people, including a child under four.
Go deeper with Google Headlines on:
COVID-19 testing
[google_news title=”” keyword=”COVID-19 testing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
COVID-19 biomarkers
- LDT Oversight Gets Long-Awaited FDA Final Rule
The final rule is sure to shake up the diagnostic industry, for better or worse, depending on who you talk to.
- mRNA Is Promising A Breakthrough In Fighting Cancer
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as ...
- Roche Dx Revenues Down 6 Percent in Q1 on Lower COVID Test Sales as Base Business Rises
Though COVID test sales were behind the decline in revenues, the firm expects there won’t be any further material impact on its sales from such tests.
- Global Cardiac Biomarkers Market Size To Worth USD 69.44 Billion By 2033 | CAGR Of 14.20%
The Global Cardiac Biomarkers Market Size was Valued at USD 18.40 Billion in 2023 and the Worldwide Cardiac Biomarkers Market Size is Expected to Reach USD 69.44 Billion by 2033, according to a ...
- How long is long Covid? New research hints at timeframe
Biomarkers for long Covid that were present in patients at eight months have largely resolved by 24 months among a cohort of people who contracted Covid-19 during Australia’s first wave.
Go deeper with Google Headlines on:
COVID-19 biomarkers
[google_news title=”” keyword=”COVID-19 biomarkers” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]